Homozygous Deficiency of Heparin Cofactor II
- 7 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (10) , 1303-1307
- https://doi.org/10.1161/01.cir.0000140763.51679.d9
Abstract
Background— Heparin cofactor II (HCII) is a hepatic serpin with significant antithrombin activity that has been implicated in coagulation, inflammation, atherosclerosis, and wound repair. Recent da...Keywords
This publication has 20 references indexed in Scilit:
- Heparin Cofactor II DeficiencyArchives of Pathology & Laboratory Medicine, 2002
- Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanismProceedings of the National Academy of Sciences, 2002
- Molecular Mechanism of Type I Congenital Heparin Cofactor (HC) II Deficiency Caused by a Missense Mutation at Reactive P2 Site: HC II TokushimaThrombosis and Haemostasis, 2001
- Thrombin signalling and protease-activated receptorsNature, 2000
- Hereditary Homozygous Heparin Cofactor II Deficiency and the Risk of Developing Venous ThrombosisThrombosis and Haemostasis, 1999
- A Heparin Cofactor II Mutation (HCII Rimini) Combined with Factor V Leiden or Type I Protein C Deficiency in Two Unrelated Thrombophilic SubjectsThrombosis and Haemostasis, 1996
- What do dysfunctional serpins tell us about molecular mobility and disease?Nature Structural & Molecular Biology, 1995
- Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11Biochemistry, 1991
- Heparin Cofactor IIOsloJournal of Biological Chemistry, 1989
- A new member of the plasma protease inhibitor gene familyNucleic Acids Research, 1986